TTM
$4.82B
YoY change
+15.6%
5Y CAGR
+19.3%
Peak year (2025)
$4.66B
Cumulative revenue
$25.69B
Revenue history chart for DexCom (DXCM) from 2000 to 2025
Latest: $4.66B
Revenue growth chart for DexCom (DXCM) from 2000 to 2025
Latest: +15.6%
Revenue history table for DexCom (DXCM) from 2000 to 2025
| 2025 | $4.66B | +15.6% | +$629.00M | ||
| 2024 | $4.03B | +11.3% | +$410.70M | ||
| 2023 | $3.62B | +24.5% | +$712.50M | ||
| 2022 | $2.91B | +18.8% | +$461.30M | ||
| 2021 | $2.45B | +27.1% | +$521.80M | ||
| 2020 | $1.93B | +30.5% | +$450.70M | ||
| 2019 | $1.48B | +43.1% | +$444.40M | ||
| 2018 | $1.03B | +43.6% | +$313.10M | ||
| 2017 | $718.50M | +25.3% | +$145.20M | ||
| 2016 | $573.30M | +42.6% | +$171.30M | ||
| 2015 | $402.00M | +55.1% | +$142.80M | ||
| 2014 | $259.20M | +62.0% | +$99.20M | ||
| 2013 | $160.00M | +60.2% | +$60.10M | ||
| 2012 | $99.90M | +31.0% | +$23.63M | ||
| 2011 | $76.27M | +56.8% | +$27.64M | ||
| 2010 | $48.63M | +63.8% | +$18.94M | ||
| 2009 | $29.69M | +201.8% | +$19.86M | ||
| 2008 | $9.84M | +112.6% | +$5.21M | ||
| 2007 | $4.63M | +113.2% | +$2.46M | ||
| 2006 | $2.17M | — | +$2.17M | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | $0.00 | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | — |
- 2025$4.66B+15.6%
- 2024$4.03B+11.3%
- 2023$3.62B+24.5%
- 2022$2.91B+18.8%
- 2021$2.45B+27.1%
- 2020$1.93B+30.5%
- 2019$1.48B+43.1%
- 2018$1.03B+43.6%
- 2017$718.50M+25.3%
- 2016$573.30M+42.6%
- 2015$402.00M+55.1%
- 2014$259.20M+62.0%
- 2013$160.00M+60.2%
- 2012$99.90M+31.0%
- 2011$76.27M+56.8%
- 2010$48.63M+63.8%
- 2009$29.69M+201.8%
- 2008$9.84M+112.6%
- 2007$4.63M+113.2%
- 2006$2.17M—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
Revenue values are taken from DexCom's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current revenue (TTM) is $4.82B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, DexCom (DXCM) reported revenue of $4.66B – grew 15.6% year-over-year.
Over 2020–2025 (5 years), DexCom revenue expanded at a +19.3% compound annual rate, sustaining 20 straight years of year-over-year growth.
The record annual revenue stands at $4.66B, reached in 2025; the historical low of $0.00 was recorded in 2000.
DexCom Revenue by Year
DexCom Revenue 2025: $4.66B
2025's revenue for DexCom came in at $4.66B, grew 15.6% from 2024. This figure represents the highest annual value in the available history.
DexCom Revenue 2024: $4.03B
DexCom posted revenue of $4.03B in 2024, grew 11.3% from 2023.
DexCom Revenue 2023: $3.62B
In 2023, DexCom reported revenue of $3.62B, grew 24.5% from 2022.
DexCom Revenue 2022: $2.91B
DexCom revenue in 2022 was $2.91B, grew 18.8% from 2021.
DexCom Revenue 2021: $2.45B
DexCom revenue in 2021 was $2.45B.
See more financial history for DexCom (DXCM).
Sector peers by Revenue
Healthcare peers of DexCom (DXCM), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
DexCom (DXCM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation